New pill could tame stubborn high blood pressure

NCT ID NCT07142356

First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times

Summary

This study tests a new drug called RTN-001 in adults whose high blood pressure is not controlled by at least two other medications. About 280 participants will take either RTN-001 or a placebo daily for 12 weeks. The main goal is to see if RTN-001 lowers blood pressure more than a placebo and to check for any side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for UNCONTROLLED HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Heart Murmurs hypertensive disorder Systolic Murmurs

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Retension Clincal Site

    RECRUITING

    Plano, Texas, 75024, United States

  • Retension Clincial Site

    RECRUITING

    Boston, Massachusetts, 02131, United States

  • Retension Clinical Site

    RECRUITING

    Tucson, Arizona, 85715, United States

  • Retension Clinical Site

    RECRUITING

    San Jose, California, 95128, United States

  • Retension Clinical Site

    RECRUITING

    West Hills, California, 91307, United States

  • Retension Clinical Site

    RECRUITING

    Waterbury, Connecticut, 06708, United States

  • Retension Clinical Site

    RECRUITING

    Orlando, Florida, 32801, United States

  • Retension Clinical Site

    RECRUITING

    Port Orange, Florida, 32127, United States

  • Retension Clinical Site

    RECRUITING

    Tampa, Florida, 33606, United States

  • Retension Clinical Site

    RECRUITING

    Lawrenceville, Georgia, 30044, United States

  • Retension Clinical Site

    RECRUITING

    Peachtree Corners, Georgia, 30092, United States

  • Retension Clinical Site

    RECRUITING

    Las Vegas, Nevada, 89109, United States

  • Retension Clinical Site

    RECRUITING

    Las Vegas, Nevada, 89121, United States

  • Retension Clinical Site

    RECRUITING

    Asheboro, North Carolina, 27203, United States

  • Retension Clinical Site

    RECRUITING

    Charlotte, North Carolina, 28210, United States

  • Retension Clinical Site

    RECRUITING

    Monroe, North Carolina, 28112, United States

  • Retension Clinical Site

    RECRUITING

    Cincinnati, Ohio, 45245, United States

  • Retension Clinical Site

    RECRUITING

    Charleston, South Carolina, 29407, United States

  • Retension Clinical Site

    RECRUITING

    Bellaire, Texas, 77401, United States

  • Retension Clinical Site

    RECRUITING

    Dallas, Texas, 75230, United States

  • Retension Clinical Site

    RECRUITING

    San Antonio, Texas, 78215, United States

  • Retension Clinical Site

    RECRUITING

    Vienna, Virginia, 22182, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.